168 related articles for article (PubMed ID: 32099846)
1. Prospective Pilot Study of Cyclophosphamide as an Adjunct Treatment in Patients With Adult-Onset Immunodeficiency Associated With Anti-interferon-γ Autoantibodies.
Laisuan W; Pisitkun P; Ngamjanyaporn P; Suangtamai T; Rotjanapan P
Open Forum Infect Dis; 2020 Feb; 7(2):ofaa035. PubMed ID: 32099846
[TBL] [Abstract][Full Text] [Related]
2. Intravenous Cyclophosphamide Therapy for Anti-IFN-γ Autoantibody-Associated
Zeng W; Tang M; Yang M; Fang G; Tang S; Zhang J
Open Forum Infect Dis; 2022 Dec; 9(12):ofac612. PubMed ID: 36519123
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated
Chetchotisakd P; Anunnatsiri S; Nanagara R; Nithichanon A; Lertmemongkolchai G
J Immunol Res; 2018; 2018():6473629. PubMed ID: 30687765
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Bortezomib for Treating Anti-Interferon-Gamma Autoantibody-Associated Adult-Onset Immunodeficiency Syndrome.
Angkasekwinai N; Suputtamongkol Y; Tantibhedhyangkul W; Onlamoon N; Phoompoung P; Pithukpakorn M; Karuphong E; Pusuwan P; Angkasekwinai P
Clin Infect Dis; 2024 Apr; 78(4):1033-1042. PubMed ID: 37947190
[TBL] [Abstract][Full Text] [Related]
5. Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States.
Hong GH; Ortega-Villa AM; Hunsberger S; Chetchotisakd P; Anunnatsiri S; Mootsikapun P; Rosen LB; Zerbe CS; Holland SM
Clin Infect Dis; 2020 Jun; 71(1):53-62. PubMed ID: 31429907
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies.
Angkasekwinai N; Suputtamongkol Y; Phoompoung P; Pithukpakorn M; Wongswat E; Umrod P; Tongsai S; Foongladda S
PLoS One; 2019; 14(4):e0215581. PubMed ID: 31022229
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections.
Chi CY; Lin CH; Ho MW; Ding JY; Huang WC; Shih HP; Yeh CF; Fung CP; Sun HY; Huang CT; Wu TS; Chang CY; Liu YM; Feng JY; Wu WK; Wang LS; Tsai CH; Ho CM; Lin HS; Chen HJ; Lin PC; Liao WC; Chen WT; Lo CC; Wang SY; Kuo CY; Lee CH; Ku CL
Medicine (Baltimore); 2016 Jun; 95(25):e3927. PubMed ID: 27336882
[TBL] [Abstract][Full Text] [Related]
8. Clinical findings of Talaromyces marneffei infection among patients with anti-interferon-γ immunodeficiency: a prospective cohort study.
Chen ZM; Li ZT; Li SQ; Guan WJ; Qiu Y; Lei ZY; Zhan YQ; Zhou H; Lin S; Wang X; Li Z; Yang F; Zeng W; Lin Y; Liu J; Zhang JQ; Ye F
BMC Infect Dis; 2021 Jun; 21(1):587. PubMed ID: 34144700
[TBL] [Abstract][Full Text] [Related]
9. Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
Igarashi T; Igarashi T; Shimizu A; Itoh Y
J Nippon Med Sch; 2013; 80(5):396-400. PubMed ID: 24189359
[TBL] [Abstract][Full Text] [Related]
10. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.
Contreras G; Tozman E; Nahar N; Metz D
Lupus; 2005; 14 Suppl 1():s33-8. PubMed ID: 15803929
[TBL] [Abstract][Full Text] [Related]
11. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies.
Wu UI; Wang JT; Sheng WH; Sun HY; Cheng A; Hsu LY; Chang SC; Chen YC
Clin Microbiol Infect; 2020 Dec; 26(12):1684.e1-1684.e6. PubMed ID: 32120037
[TBL] [Abstract][Full Text] [Related]
12. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.
Hase I; Morimoto K; Sakagami T; Ishii Y; van Ingen J
Diagn Microbiol Infect Dis; 2017 Aug; 88(4):308-315. PubMed ID: 28633901
[TBL] [Abstract][Full Text] [Related]
13. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody.
Czaja CA; Merkel PA; Chan ED; Lenz LL; Wolf ML; Alam R; Frankel SK; Fischer A; Gogate S; Perez-Velez CM; Knight V
Clin Infect Dis; 2014 Mar; 58(6):e115-8. PubMed ID: 24336756
[TBL] [Abstract][Full Text] [Related]
14. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.
Jovancevic B; Lindholm C; Pullerits R
Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
Yamaji K; Kim YJ; Tsuda H; Takasaki Y
Ther Apher Dial; 2008 Aug; 12(4):298-305. PubMed ID: 18789117
[TBL] [Abstract][Full Text] [Related]
16. The long-term prognosis of lupus nephritis patients treated with intravenous cyclophosphamide.
Matsuyama N; Morimoto S; Tokano Y; Amano H; Nozawa K; Isonuma H; Hashimoto H; Takasaki Y
Intern Med; 2010; 49(9):823-8. PubMed ID: 20453401
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
Yaguchi H; Sakushima K; Takahashi I; Nishimura H; Yashima-Yamada M; Nakamura M; Tsuzaka K; Maruo Y; Takahashi T; Yabe I; Sasaki H
Intern Med; 2013; 52(9):969-72. PubMed ID: 23648715
[TBL] [Abstract][Full Text] [Related]
18. Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand.
Wongkulab P; Wipasa J; Chaiwarith R; Supparatpinyo K
PLoS One; 2013; 8(9):e76371. PubMed ID: 24086734
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection.
Phoompoung P; Ankasekwinai N; Pithukpakorn M; Foongladda S; Umrod P; Suktitipat B; Mahasirimongkol S; Kiertiburanakul S; Suputtamongkol Y
PLoS One; 2017; 12(4):e0176342. PubMed ID: 28437431
[TBL] [Abstract][Full Text] [Related]
20. Disseminated Mycobacterium abscessus subsp. massiliense infection in a Good's syndrome patient negative for human immunodeficiency virus and anti-interferon-γ autoantibody: a case report.
Imoto W; Yamada K; Hajika Y; Okamoto K; Myodo Y; Niki M; Kuwabara G; Yamairi K; Shibata W; Yoshii N; Nakaie K; Yoshizawa K; Namikawa H; Watanabe T; Asai K; Moro H; Kaneko Y; Kawaguchi T; Itoh Y; Kakeya H
BMC Infect Dis; 2020 Jun; 20(1):431. PubMed ID: 32563248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
